Suhail Ayesh
Corporate Officer/Principal bij The Hebrew University of Jerusalem
Profiel
Suhail Ayesh is Senior Researcher of BioCancell Therapeutics, Inc. He is Professor of Molecular Biochemistry and Gene Therapy at the Hebrew University of Jerusalem.
Mr. Ayesh is a Director of the Molecular Genetics Laboratory for Makassed Hospital.
Actieve functies van Suhail Ayesh
| Bedrijven | Functie | Begin |
|---|---|---|
| The Hebrew University of Jerusalem | Corporate Officer/Principal | - |
| Al-Makassed Hospital | Corporate Officer/Principal | - |
Eerdere bekende functies van Suhail Ayesh
| Bedrijven | Functie | Einde |
|---|---|---|
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
| Al-Makassed Hospital |
